NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

CompletedN/A

Sponsor: Pfizer

Conditions: Covid-19

Interventions: nirmatrelvir, ritonavir

Countries: Saudi Arabia

The aim of this study is to describe the baseline demographic, clinical characteristics, and Healthcare Resource Use (HCRU) of adult (≥18 years) COVID-19 patients who have been prescribed nirmatrelvir, ritonavir treatment.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Confirmed COVID-19 infection during the study observation period
* Nirmatrelvir, ritonavir written prescription

Exclusion Criteria:

* None

Locations (3)

Jeddah, Saudi Arabia
Riyadh, Saudi Arabia
Riyadh, Saudi Arabia